Case Fatalities in Hospitalised COVID-19 Patients in the UK
NCT ID: NCT04527458
Last Updated: 2020-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
70000 participants
OBSERVATIONAL
2020-02-24
2020-08-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2
NCT04318314
Risks of Bacterial and Fungal Superinfection in Patients With COVID-19
NCT05256316
Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic
NCT06334731
Study of the Effect of Systematic Screening of Residents and Caregivers With Covid-19 by Nasopharyngeal Swab (RT-PCR)
NCT05085522
French COVID Cohort
NCT04262921
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hospitalisations
All hospitalised COVID patients
Patient Characteristics
Characteristics of the patients
COVID-19 treatments
Specific treatments used on COVID-19 patients
Differences in triage
Triage criteria for treating COVID-19 patients
Surge capacity
Capacity of hospitals
Critical care
All hospitalised COVID patients in critical care
Patient Characteristics
Characteristics of the patients
COVID-19 treatments
Specific treatments used on COVID-19 patients
Differences in triage
Triage criteria for treating COVID-19 patients
Surge capacity
Capacity of hospitals
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient Characteristics
Characteristics of the patients
COVID-19 treatments
Specific treatments used on COVID-19 patients
Differences in triage
Triage criteria for treating COVID-19 patients
Surge capacity
Capacity of hospitals
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
International Severe Acute Respiratory and Emerging Infection Consortium
OTHER
BREATHE Health Data Research Hub
UNKNOWN
University of Edinburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Annemarie B Docherty
Role: PRINCIPAL_INVESTIGATOR
Usher Institute, University of Edinburgh
Ewen M Harrison
Role: PRINCIPAL_INVESTIGATOR
Usher Institute, University of Edinburgh
Rachel H Mulholland
Role: PRINCIPAL_INVESTIGATOR
Usher Institute, University of Edinburgh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Edinburgh
Edinburgh, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, Holden KA, Read JM, Dondelinger F, Carson G, Merson L, Lee J, Plotkin D, Sigfrid L, Halpin S, Jackson C, Gamble C, Horby PW, Nguyen-Van-Tam JS, Ho A, Russell CD, Dunning J, Openshaw PJ, Baillie JK, Semple MG; ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985.
Related Links
Access external resources that provide additional context or updates about the study.
ISARIC 4C website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ISARIC_COVID_CF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.